Stuttgart - Delayed Quote EUR
Wave Life Sciences Ltd. (1U5.SG)
5.85
-0.30
(-4.88%)
As of 6:21:42 PM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | -- | -- |
| Sales | -- | -- |
| Net Shares Purchased (Sold) | -- | -- |
| Total Insider Shares Held | -- | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 45.22 - 46.00 per share. | Direct | 2,273,804 | Mar 15, 2019 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 124,000 | Mar 15, 2019 |
| PANZARA MICHAEL A Officer | Sale at price 48.00 per share. | Direct | 336,000 | Mar 11, 2019 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2019 |
| VARGEESE CHANDRA PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2019 |
| FRANCIS CHRISTOPHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2019 |
| PANZARA MICHAEL A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2019 |
| REGNANTE KEITH Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2019 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 36.38 - 37.47 per share. | Direct | 281,456 | Feb 19, 2019 |
| VARGEESE CHANDRA PH.D. Officer | Sale at price 36.84 per share. | Direct | 75,706 | Feb 19, 2019 |
| FRANCIS CHRISTOPHER Officer | Sale at price 36.84 per share. | Direct | 62,959 | Feb 19, 2019 |
| PANZARA MICHAEL A Officer | Sale at price 36.84 per share. | Direct | 67,674 | Feb 19, 2019 |
| REGNANTE KEITH Chief Financial Officer | Sale at price 36.84 per share. | Direct | 47,818 | Feb 19, 2019 |
| VERDINE GREGORY L Director | Sale at price 38.59 - 39.52 per share. | Direct | 582,849 | Nov 14, 2018 |
| FRANCIS CHRISTOPHER Officer | Sale at price 56.00 per share. | Direct | 648,200 | Sep 25, 2018 |
| FRANCIS CHRISTOPHER Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 28,706 | Sep 25, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Sale at price 55.00 per share. | Direct | 165,000 | Sep 24, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 7,440 | Sep 24, 2018 |
| REGNANTE KEITH Chief Financial Officer | Sale at price 55.00 per share. | Direct | 1,622,500 | Sep 24, 2018 |
| REGNANTE KEITH Chief Financial Officer | Conversion of Exercise of derivative security at price 20.89 per share. | Direct | 616,255 | Sep 24, 2018 |
| FRANCIS CHRISTOPHER Officer | Sale at price 37.25 - 38.22 per share. | Direct | 913,054 | Jul 9, 2018 |
| FRANCIS CHRISTOPHER Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 60,750 | Jul 9, 2018 |
| FRANCIS CHRISTOPHER Officer | Sale at price 45.50 - 48.00 per share. | Direct | 2,290,376 | Jun 1, 2018 |
| FRANCIS CHRISTOPHER Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 121,500 | Jun 1, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 45.00 per share. | Direct | 1,426,995 | May 30, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 78,643 | May 30, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 45.00 per share. | Direct | 823,005 | May 2, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 45,357 | May 2, 2018 |
| FRANCIS CHRISTOPHER Officer | Sale at price 51.80 - 55.95 per share. | Direct | 1,198,760 | Feb 20, 2018 |
| FRANCIS CHRISTOPHER Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 51,872 | Feb 20, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 51.01 - 51.62 per share. | Direct | 139,783 | Feb 16, 2018 |
| PANZARA MICHAEL A Officer | Sale at price 52.10 per share. | Direct | 26,623 | Feb 16, 2018 |
| REGNANTE KEITH Chief Financial Officer | Sale at price 51.85 per share. | Direct | 16,385 | Feb 16, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Sale at price 50.00 per share. | Direct | 100,000 | Feb 15, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 4,960 | Feb 15, 2018 |
| PANZARA MICHAEL A Officer | Sale at price 50.00 per share. | Direct | 937,500 | Feb 15, 2018 |
| PANZARA MICHAEL A Officer | Conversion of Exercise of derivative security at price 21.69 per share. | Direct | 406,688 | Feb 15, 2018 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Sale at price 40.00 per share. | Direct | 80,000 | Jan 23, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 4,960 | Jan 23, 2018 |
| FRANCIS CHRISTOPHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2018 |
| PANZARA MICHAEL A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2018 |
| REGNANTE KEITH Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 23, 2018 |
| VARGEESE CHANDRA PH.D. Officer | Sale at price 35.00 per share. | Direct | 52,500 | Nov 22, 2017 |
| VARGEESE CHANDRA PH.D. Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 3,720 | Nov 22, 2017 |
| TANAKA MASAHARU Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 24.19 - 24.22 per share. | Indirect | 502,301 | Sep 18, 2017 |
| VERDINE GREGORY L Director | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 7, 2017 |
| PANZARA MICHAEL A Officer | Sale at price 16.67 per share. | Direct | 123,620 | Jul 12, 2017 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2017 |
Related Tickers
50BA.F Bicycle Therapeutics plc
6.75
-11.18%
38I.DU Intellia Therapeutics Inc
7.15
-2.05%
AB3A.F Sarepta Therapeutics, Inc.
51.84
-1.18%
TRDA Entrada Therapeutics, Inc.
8.77
+0.63%
ATXS Astria Therapeutics, Inc.
5.18
-0.38%
VRDN Viridian Therapeutics, Inc.
13.42
-0.67%
APGE Apogee Therapeutics, Inc.
36.50
-0.08%
ACRV Acrivon Therapeutics, Inc.
1.9199
-4.01%
LYRA Lyra Therapeutics, Inc.
0.0958
+3.46%
GUTS Fractyl Health, Inc.
1.3550
+1.88%